RxDoctor Payments Data

Ehtisham Mahmud, MD

Interventional Cardiology · San Diego, CANPI 1730112335

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 35.6% of the total. Reporting peaked in 2023 at $49,871 and has fallen 97.3% since, to $1,328 in 2025.

$108,556in general payments, 2019–2025

Across 92 payments — averaging $1179.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$39K
  • Abiomed$27K
  • Medtronic$13K
  • Philips North America LLC$10K
  • Cathworks, Inc.$10K
  • Shockwave Medical, Inc$4K
  • plus $6K from 10 others
$1,132,952in research payments, 2019–2025

Across 151 payments — averaging $7502.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$478K
  • Cardiovascular Systems Inc.$213K
  • Cathworks, Inc.$145K
  • Abbott$119K
  • Corindus Inc.$87K
  • Shockwave Medical, Inc$47K
  • plus $43K from 3 others
$249,999in ownership & investment interests, 2019–2025

Across 2 payments — averaging $125,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Vektor Medical Inc.$250K

What the payments were for

  • Consulting fees$44,61541%
  • Speaking & faculty fees$45,35042%
  • Travel & lodging$14,32613%
  • Food & beverage$4,2654%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$108,556 in reported general payments places this provider in the 85th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$153,397
Medicare patients
196
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →